Provided by Tiger Trade Technology Pte. Ltd.

ACADIA Pharmaceuticals

26.93
+0.13000.49%
Post-market: 26.20-0.7300-2.71%19:00 EST
Volume:1.45M
Turnover:39.12M
Market Cap:4.56B
PE:17.47
High:27.35
Open:26.77
Low:26.60
Close:26.80
52wk High:27.73
52wk Low:13.40
Shares:169.18M
Float Shares:115.85M
Volume Ratio:1.03
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.54
EPS(LYR):1.37
ROE:34.95%
ROA:5.11%
PB:4.97
PE(LYR):19.71

Loading ...

RBC Cuts Price Target on ACADIA Pharmaceuticals to $32 From $34, Keeps Outperform Rating

MT Newswires Live
·
Nov 06

ACADIA Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Nov 06

Positive Indicators and Growth Prospects Lead to Buy Rating for ACADIA Pharmaceuticals

TIPRANKS
·
Nov 06

U.S. RESEARCH ROUNDUP-Acadia Pharmaceuticals, Applovin, Centuri Holdings

Reuters
·
Nov 06

ACADIA Pharmaceuticals: Strategic Expansion and Strong Market Presence Drive Buy Rating

TIPRANKS
·
Nov 06

Stock Track | ACADIA Pharmaceuticals Soars 7.43% After-Hours on Strong Q3 Results and Raised 2025 Guidance

Stock Track
·
Nov 06

ACADIA Pharmaceuticals Q3 EPS $0.42 May Not Be Comparable To $0.14 Estimate, Sales $278.633M Beat $276.466M Estimate

Benzinga
·
Nov 06

Acadia Pharmaceuticals Raises 2025 Revenue Guidance to Up to $1.095 Billion

Reuters
·
Nov 06

BRIEF-Acadia Pharmaceuticals Q3 EPS USD 0.42

Reuters
·
Nov 06

ACADIA Pharmaceuticals Inc Outlook 2025 Total Revenues in the Range of $1.070 Bln to $1.095 Bln

THOMSON REUTERS
·
Nov 06

ACADIA Pharmaceuticals Board Chair Daniel Soland Resigns

Reuters
·
Nov 04

ACADIA Pharmaceuticals (ACAD): Exploring Valuation After Strong Share Price Momentum and Pipeline Progress

Simply Wall St.
·
Oct 30

ACADIA Pharmaceuticals Advances Phase 3 Study for Lewy Body Dementia Psychosis Treatment

TIPRANKS
·
Oct 28

Does the Halted Carbetocin Trial and Investigation Shift the Growth Outlook for ACADIA Pharmaceuticals (ACAD)?

Simply Wall St.
·
Oct 23

This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Benzinga_recent_news
·
Oct 21

ACADIA Pharmaceuticals Initiated at Buy by Citigroup

Dow Jones
·
Oct 21

ACADIA Pharmaceuticals Inc : Citigroup Initiates Coverage With Buy Rating; Price Target $33

THOMSON REUTERS
·
Oct 21

ACADIA Pharmaceuticals: Hold Rating Amid Pipeline Shifts and Product Focus

TIPRANKS
·
Oct 20

ACADIA Pharmaceuticals Inc. to Release Third Quarter 2025 Financial Results

Reuters
·
Oct 16

ACADIA Pharmaceuticals (ACAD) Receives a Buy from RBC Capital

TIPRANKS
·
Oct 09